{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:40:51Z","timestamp":1789072851308,"version":"build-2803163510"},"reference-count":125,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.autrev.2018.01.026","type":"journal-article","created":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T17:04:24Z","timestamp":1528304664000},"page":"746-754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Immune checkpoint failures in inflammatory myopathies: An overview"],"prefix":"10.1016","volume":"17","author":[{"given":"Sandrine","family":"Herbelet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan L.","family":"De Bleecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2018.01.026_bb0005","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1365-2990.2010.01153.x","article-title":"Review: an update on inflammatory and autoimmune myopathies","volume":"37","author":"Dalakas","year":"2011","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0010","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.nmd.2013.07.007","article-title":"The ENMC myositis muscle biopsy study group, B. De Paepe. 193rd ENMC international workshop: pathology diagnosis of idiopathic inflammatory myopathies, 30 November\u20132 December 2012, Naarden, the Netherlands","volume":"23","author":"De Bleecker","year":"2013","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.autrev.2018.01.026_bb0015","first-page":"4143","article-title":"Complemnt membrane attack is realted with immune-mediated necrotizing myopathy","volume":"7","author":"Cong","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0020","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMra1402225","article-title":"Inflammatory muscle diseases","volume":"372","author":"Dalakas","year":"2015","journal-title":"NEJM"},{"key":"10.1016\/j.autrev.2018.01.026_bb0025","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJM200103013440907","article-title":"Tolerance and autoimmunity","volume":"344","author":"Kamradt","year":"2001","journal-title":"NEJM"},{"key":"10.1016\/j.autrev.2018.01.026_bb0030","doi-asserted-by":"crossref","first-page":"408","DOI":"10.4049\/jimmunol.181.1.408","article-title":"Functional tolerance of CD8+ T cells induced by muscle-specific antigen expression","volume":"181","author":"Calbo","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jneuroim.2003.11.013","article-title":"Thymic myoid cells express high levels of muscle genes","volume":"148","author":"Mesnard-Rouiller","year":"2004","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0040","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2169\/internalmedicine.38.155","article-title":"Dermatomyositis associated with invasive thymoma","volume":"38","author":"Ago","year":"1999","journal-title":"Intern Med J"},{"key":"10.1016\/j.autrev.2018.01.026_bb0045","first-page":"S143","article-title":"Paraneoplastic disorders in thymoma patients","volume":"9 (","author":"Evoli","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2018.01.026_bb0050","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1365-4362.1992.tb02675.x","article-title":"Primary thymic carcinoma and its association with dermatomyositis and pure red cell aplasia","volume":"31","author":"Fong","year":"1992","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0055","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00595-007-3601-x","article-title":"Successful resection of dermatomyositis associated with thymic carcinoma: report of a case","volume":"38","author":"Takahashi","year":"2008","journal-title":"Surg Today"},{"key":"10.1016\/j.autrev.2018.01.026_bb0060","first-page":"68","article-title":"Dermatomyositis as first clinical appearance for a thymic epidermoid cell carcinoma","volume":"81","author":"Iacovelli","year":"2010","journal-title":"Acta Biomed"},{"key":"10.1016\/j.autrev.2018.01.026_bb0065","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s11748-012-0144-x","article-title":"Paraneoplastic dermatomyositis as presentation of thymic carcinoma","volume":"61","author":"Dell'Amore","year":"2013","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"10.1016\/j.autrev.2018.01.026_bb0070","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1186\/s12885-015-1968-4","article-title":"Choroidal metastases from thymic carcinoma during pregnancy: case report","volume":"15","author":"Haen","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.autrev.2018.01.026_bb0075","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1023\/A:1008321802223","article-title":"Polymyositis with respiratory muscle weakness requiring mechanical ventilation in a patient with metastatic thymoma treated with octreotide","volume":"10","author":"Rini","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0080","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2009.22.1176","article-title":"Thymic carcinoma associated with paraneoplastic polymyositis","volume":"27","author":"Inoue","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0085","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s00115-009-2689-1","article-title":"Polymyositis associated with thymoma","volume":"80","author":"Jordan","year":"2009","journal-title":"Nervenarzt"},{"key":"10.1016\/j.autrev.2018.01.026_bb0090","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2010.28.7946","article-title":"Thymoma-associated paraneoplastic polymyositis","volume":"28","author":"Kelly","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0095","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1097\/JTO.0000000000000324","article-title":"Multi-organ autoimmune manifestations associated with thymoma","volume":"10","author":"Thomas","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0100","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ana.410230111","article-title":"Expression of immunoreactive major histocompatibility complex products in human skeletal muscles","volume":"23","author":"Karpati","year":"1988","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0105","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/sj.icb.7100161","article-title":"Too dangerous to ignore: self-tolerance and the control of ignorant autoreactive T cells","volume":"86","author":"Parish","year":"2008","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0110","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12016-011-8294-7","article-title":"Molecular mimicry as a mechanism of autoimmune disease","volume":"42","author":"Cusick","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0115","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1002\/art.10566","article-title":"Self epitopes shared between human skeletal myosin and Streptococcus pyogenes M5 protein are targets of immune responses in active juvenile dermatomyositis","volume":"46","author":"Massa","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.01.026_bb0120","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/00002281-200309000-00013","article-title":"Update on juvenile dermatomyositis: new advances in understanding its etiopathogenesis","volume":"15","author":"Wargula","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0125","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/BOR.0b013e32834b5457","article-title":"State of the art: what we know about infectious agents and myositis","volume":"23","author":"Gan","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0130","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1752-1947-8-54","article-title":"Onset of juvenile dermatomyositis following varicella infection in a 12-months-old child: a case report","volume":"8","author":"McCrea","year":"2014","journal-title":"J Med Case Reports"},{"key":"10.1016\/j.autrev.2018.01.026_bb0135","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/art.21068","article-title":"History of infection before the onset of juvenile dermatomyositis: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases research registry","volume":"53","author":"Pachman","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.01.026_bb0140","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/rheumatology\/ken038","article-title":"Assessment of an infectious disease history preceding juvenile dermatomyositis symptom onset","volume":"47","author":"Manhliot","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2018.01.026_bb0145","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12969-016-0118-0","article-title":"Characteristics and outcome of children with juvenile dermatomyositis in cape town: a cross-sectional study","volume":"14","author":"Okong'O","year":"2016","journal-title":"Pediatr Rheumatol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0150","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0022-510X(94)90244-5","article-title":"Search for persistent enterovirus infection of muscle with inflammatory myopathies","volume":"125","author":"Fox","year":"1994","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2018.01.026_bb0155","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0140-6736(86)92429-3","article-title":"Polymyositis and molecular mimicry, a mechanism of autoimmunity","volume":"328","author":"Walker","year":"1986","journal-title":"The Lancet"},{"key":"10.1016\/j.autrev.2018.01.026_bb0160","first-page":"13","article-title":"Diagnostic utility of auto-antibodies in inflammatory muscle diseases","volume":"2","author":"Allenbach","year":"2015","journal-title":"J Neurodev Disord"},{"key":"10.1016\/j.autrev.2018.01.026_bb0165","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jamaneurol.2015.1207","article-title":"M. Clinical features and treatment outcomes of necrotizing autoimmune myopathy","volume":"72","author":"Kassardjian","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/mus.20649","article-title":"Myeloid dendritic cells in inclusion-body myositis and polymyositis","volume":"35","author":"Greenberg","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2018.01.026_bb0175","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/ar2139","article-title":"Immune mechanisms in the pathogenesis of idiopathic inflammatory myopathies","volume":"9","author":"Grundtman","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2018.01.026_bb0180","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/0140-6736(92)91134-T","article-title":"Viruses in idiopathic inflammatory myopathies: absence of candidate viral genomes in muscle","volume":"339","author":"Leff","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2018.01.026_bb0185","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0165-5728(02)00026-7","article-title":"Regulation of class I MHC expression in skeletal muscle: deleterious effect of aberrant expression of myogenesis","volume":"125","author":"Pavlath","year":"2002","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0190","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/gt.2010.124","article-title":"Skeletal muscle cells: from local inflammatory response to active immunity","volume":"18","author":"Marino","year":"2012","journal-title":"Gene Ther"},{"key":"10.1016\/j.autrev.2018.01.026_bb0195","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/PAI.0b013e31827d7f16","article-title":"Major histocompatibility complex class I and II expression in idiopathic inflammatory myopathy","volume":"21","author":"Das","year":"2015","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0200","doi-asserted-by":"crossref","first-page":"661","DOI":"10.4049\/jimmunol.149.2.661","article-title":"Human myoblasts as antigen-presenting cells","volume":"149","author":"Goebels","year":"1992","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0205","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1365-2249.1995.tb03861.x","volume":"102","author":"Garlepp","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0210","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/BF03401683","article-title":"Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes","volume":"3","author":"Fu","year":"1997","journal-title":"Mol Med"},{"key":"10.1016\/j.autrev.2018.01.026_bb0215","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0165-5728(01)00272-7","article-title":"Presentation by myoblasts of an epitope from endogenous acetylcholine receptor indicates a potential role in the spreading of the immune response","volume":"115","author":"Curnow","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0220","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/brain\/awg114","article-title":"Muscle fibers and cultured muscle cells express the B7.1\/2-related inducible co-stimulatory molecule, ICOSL: implications for the pathogenesis of inflammatory myopathies","volume":"126","author":"Wiendl","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2018.01.026_bb0225","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/sj.gt.3302293","article-title":"Muscle stem cells can act as antigen-presenting cells: implication for gene therapy","volume":"11","author":"Cao","year":"2004","journal-title":"Gene Ther"},{"key":"10.1016\/j.autrev.2018.01.026_bb0230","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0002-9440(10)62513-8","article-title":"Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies","volume":"159","author":"Englund","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0235","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0002-9440(10)65141-3","article-title":"Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies","volume":"155","author":"Murata","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0240","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.bbadis.2014.05.034","article-title":"Dermatomyositis, polymyositis and immune-mediated necrotizing myopathies","volume":"1852","author":"Luo","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.autrev.2018.01.026_bb0245","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2169\/internalmedicine.47.0967","article-title":"Flow cytometric analysis of lymphocyte subpopulations and Th1\/Th2 balance in patients with polymyositis and dermatomyositis","volume":"47","author":"Ishii","year":"2008","journal-title":"Intern Med J"},{"key":"10.1016\/j.autrev.2018.01.026_bb0250","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/cei.12311","article-title":"Preferential infiltration of interleukin-4-producing CXCR4+ T cells in the lesional muscle but not skin of patients with dermatomyositis","volume":"177","author":"Fujiyama","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0255","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/art.11428","article-title":"Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis","volume":"50","author":"Page","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.01.026_bb0260","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1046\/j.1365-2567.2000.00048.x","article-title":"Regulation of T-cell apoptosis: a mixed lymphocyte reaction model","volume":"100","author":"O'Flaherty","year":"2000","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2018.01.026_bb0265","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.immuni.2007.03.016","article-title":"Fas-mediated elimination of antigen-presenting cells and autoreactive T cells contribute to prevention of autoimmunity","volume":"26","author":"Stranges","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2018.01.026_bb0270","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/40657","article-title":"Inhibition of death receptor signals by cellular FLIP","volume":"388","author":"Irmler","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2018.01.026_bb0275","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/mus.10462","article-title":"Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies","volume":"28","author":"Figarella-Branger","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2018.01.026_bb0280","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1093\/rheumatology\/keu258","article-title":"Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease","volume":"53","author":"Gono","year":"2014","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2018.01.026_bb0285","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/cei.12445","article-title":"Cytokines in immune-mediated inflammatory myopathies: cellular sources, multiple actions and therapeutic implications","volume":"178","author":"Moran","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0290","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/art.1780400514","article-title":"Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies","volume":"40","author":"Lundberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.01.026_bb0295","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s004010000324","article-title":"Immunolocalization of FAS and FAS ligand in inflammatory myopathies","volume":"101","author":"De Bleecker","year":"2001","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0300","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/(SICI)1097-4598(199706)20:6<702::AID-MUS7>3.0.CO;2-C","article-title":"Expression of Fas antigen is not associated with apoptosis in human myopathies","volume":"20","author":"Inukai","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2018.01.026_bb0305","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.4049\/jimmunol.164.10.5459","article-title":"The inhibition of apoptosis in myositis and in normal muscle cells","volume":"164","author":"Nagaraju","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0310","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0165-5728(00)00381-7","article-title":"T-cell anti-apoptotic mechanisms in inflammatory myopathies","volume":"111","author":"Vattemi","year":"2000","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036444","article-title":"Immunological tolerance to muscle autoantigens involves peripheral deletion of autoreactive CD8+ T cells","volume":"7","author":"Franck","year":"2012","journal-title":"Plos One"},{"key":"10.1016\/j.autrev.2018.01.026_bb0320","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/brain\/120.6.929","article-title":"Cytotoxic mechanisms in inflammatory myopathies. Co-expression of Fas and protective Bcl-2 in muscle fibers and inflammatory cells","volume":"120","author":"Behrens","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.autrev.2018.01.026_bb0325","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0022-510X(99)00041-6","article-title":"Bcl-2 and Bax protein expression in human myopathies","volume":"164","author":"Oliv\u00e9","year":"1999","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.autrev.2018.01.026_bb0330","doi-asserted-by":"crossref","first-page":"8983","DOI":"10.1038\/sj.onc.1207115","article-title":"PI3K\/Akt and apoptosis: size matters","volume":"22","author":"Franke","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.autrev.2018.01.026_bb0335","doi-asserted-by":"crossref","DOI":"10.1111\/j.1600-065X.2009.00782.x","article-title":"Molecular mechanism and function of CD40\/CD40L engagement in the immune system","volume":"229","author":"Elgueta","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2018.01.026_bb0340","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1006\/clim.1999.4743","article-title":"Costimulatory markers in muscle of patients with idiopathic inflammatory myopathies and in cultured muscle cells","volume":"92","author":"Nagaraju","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0345","doi-asserted-by":"crossref","first-page":"6593","DOI":"10.4049\/jimmunol.164.12.6593","article-title":"Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: role of CD40-CD40 ligand interaction in IL-6, IL-8, IL-15, and monocyte chemoattractant protein-1 production","volume":"164","author":"Sugiura","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0350","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1046\/j.1365-2567.2001.01250.x","article-title":"The contributions of T-cell anergy to peripheral T-cell tolerance","volume":"103","author":"Lechler","year":"2001","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2018.01.026_bb0355","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1126\/science.1900952","article-title":"Split anergy in a CD8+ T cell: receptor-dependent cytolysis in the absence of interleukin-2 production","volume":"251","author":"Otten","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.autrev.2018.01.026_bb0360","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1001\/jamadermatol.2014.2233","article-title":"Drug-associated dermatomyositis following ipilimumab therapy. A novel immune-mediated adverse event associated with cytotoxic T-lymphocyte antigen 4 blockade","volume":"151","author":"Ali","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0365","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor \u03b1-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0370","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/eji.200636435","article-title":"Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells","volume":"37","author":"Wang","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0375","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2353\/ajpath.2009.080422","article-title":"Role of regulatory T cells in a new mouse model of experimental autoimmune myositis","volume":"174","author":"Allenbach","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105353","article-title":"Increased presence of FOXP3+regulatory T cells in inflamed muscle of patients with active juvenile dermatomyositis compared to peripheral blood","volume":"9","author":"Vercoulen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2018.01.026_bb0385","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jaut.2010.07.006","article-title":"Characterization of regulatory T cells in patients with dermatomyositis","volume":"35","author":"Antiga","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2018.01.026_bb0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088788","article-title":"Th1 response and systemic Treg deficiency in inclusion body myositis","volume":"9","author":"Allenbach","year":"2014","journal-title":"Plos One"},{"key":"10.1016\/j.autrev.2018.01.026_bb0395","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jneuroim.2010.03.013","article-title":"FOXP3+ T regulatory cells in idiopathic inflammatory myopathies","volume":"225","author":"Waschbisch","year":"2010","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0400","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/cei.12475","article-title":"Quantitative T cell subsets profile in peripheral blood from patients with idiopathic inflammatory myopathies: tilting the balance towards proinflammatory and pro-apoptotic subsets","volume":"179","author":"Espinosa-Ortega","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0405","doi-asserted-by":"crossref","first-page":"a007146","DOI":"10.1101\/cshperspect.a007146","article-title":"Central B-cell tolerance","volume":"4","author":"Pelanda","year":"2012","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0410","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1146\/annurev.immunol.21.120601.141152","article-title":"BAFF and APRIL: a tutorial on B cell survival","volume":"21","author":"Mackay","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0415","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.coi.2008.09.001","article-title":"B-cell tolerance checkpoints in health and autoimmunity","volume":"20","author":"Meffre","year":"2008","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0420","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1136\/ard.2008.091405","article-title":"Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies","volume":"68","author":"Kry\u0161t\u016ffkov\u00e1","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.01.026_bb0425","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1093\/rheumatology\/keq151","article-title":"Idiopathic inflammatory myopathies, signified by distinctive peripheral cytokines, chemokines and the TNF family members B-cell activating factor and a proliferation inducing ligand","volume":"49","author":"Szodoray","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2018.01.026_bb0430","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jneuroim.2012.04.006","article-title":"The expression of BAFF in the muscles of patients with dermatomyositis","volume":"249","author":"Baek","year":"2012","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0435","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2217\/bmm.13.124","article-title":"B-cell activating factor as a serological biomarker for polymyositis and dermatomyositis","volume":"8","author":"Peng","year":"2014","journal-title":"Biomark Med"},{"key":"10.1016\/j.autrev.2018.01.026_bb0445","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1186\/s13075-014-0454-8","article-title":"Expression of BAFF receptors in muscle tissue of myositis patients with anti-Jo-1 or anti-Ro52\/anti-Ro60 autoantibodies","volume":"16","author":"Kry\u0161t\u016ffkov\u00e1","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2018.01.026_bb0450","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/antib3010116","article-title":"B cell tolerance in health and disease","volume":"3","author":"Gururajan","year":"2014","journal-title":"Antibodies"},{"key":"10.1016\/j.autrev.2018.01.026_bb0455","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1002\/art.27465","article-title":"Expression of toll-like receptor 3 and toll-like receptor 7 in muscle is characteristic of inflammatory myopathy and is differentially regulated by Th1 and Th17 cytokines","volume":"62","author":"Tournadre","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.01.026_bb0460","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10067-009-1316-7","article-title":"Expression of TLR2, TLR4 and TLR9 in dermatomyositis and polymyositis","volume":"29","author":"Kim","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0465","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/NEN.0b013e31826bf7f3","article-title":"Toll-like receptors promote inflammation in idiopathic inflammatory myopathies","volume":"71","author":"Brunn","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0470","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/art.24411","article-title":"Extranodal lymphoid microstructures in inflamed muscle and disease severity of new-onset juvenile dermatomyositis","volume":"60","author":"L\u03ccpez de Padilla","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.01.026_bb0475","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/eji.201343315","article-title":"The Vh repertoire and clonal diversification of B cells in inflammatory myopathies","volume":"44","author":"McIntyre","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0480","doi-asserted-by":"crossref","first-page":"547","DOI":"10.4049\/jimmunol.178.1.547","article-title":"A local antigen-driven humoral response is present in the inflammatory myopathies","volume":"178","author":"Bradshaw","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0485","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/mus.21739","article-title":"Permissive environment for B-cell maturation in myositis muscle in absence of B-cell follicles","volume":"42","author":"Salajegheh","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2018.01.026_bb0490","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0960-8966(96)00015-6","article-title":"Peripheral lymphoid tissue-like adhesion molecule expression in nodular infiltrates in inflammatory myopathies","volume":"6","author":"De Bleecker","year":"1996","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.autrev.2018.01.026_bb0495","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1172\/JCI78084","article-title":"Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity","volume":"125","author":"Suurmond","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2018.01.026_bb0500","first-page":"2668","article-title":"Regulatory T cells and B cells: implication on autoimmune diseases","volume":"6","author":"Wang","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0505","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1084\/jem.20041367","article-title":"Enhanced autoantigen expression in regenerating muscle cells in idiopathic inflammatory myopathies","volume":"4","author":"Casciola-Rosen","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2018.01.026_bb0510","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/nan.12380","article-title":"Integrated classification of inflammatory myopathies","volume":"43","author":"Allenbach","year":"2017","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0515","doi-asserted-by":"crossref","DOI":"10.1111\/joim.12451","article-title":"Myositis-specific autoantibodies: an important tool to support diagnosis of myositis","author":"Betteridge","year":"2016","journal-title":"J Intern Med"},{"key":"10.1016\/j.autrev.2018.01.026_bb0520","article-title":"Significant decrease in peripheral regulatory B cells is an immunopathogenic feature of dermatomyositis","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2018.01.026_bb0525","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/ard.60.12.1137","article-title":"Difference in B cell activation between dermatomyositis and polymyositis: analysis of the expression of RP105 on peripheral blood B cells","volume":"60","author":"Kikuchi","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.01.026_bb0530","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/2162-3619-1-36","article-title":"CD19: a biomarker for B cell development, lymphoma diagnosis and therapy","volume":"1","author":"Wang","year":"2012","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0535","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fimmu.2014.00055","article-title":"Self-antigen presentation by dendritic cells in autoimmunity","volume":"5","author":"Hopp","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0540","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12026-011-8217-y","article-title":"Dendritic cells and the maintenance of self-tolerance","volume":"50","author":"Morel","year":"2011","journal-title":"Immunol Res"},{"issue":"7","key":"10.1016\/j.autrev.2018.01.026_bb0545","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/intimm\/dxv001","article-title":"Experimental myositis inducible via transfer of dendritic cells presenting a skeletal C protein-derived CD8 epitope peptide","author":"Okiyama","year":"2015","journal-title":"Int Immunol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0550","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/BOR.0b013e3283157538","article-title":"Dendritic cells and the immunopathogenesis of idiopathic inflammatory myopathies","volume":"20","author":"L\u03ccpez de Padilla","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0555","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3899\/jrheum.120590","article-title":"Fascin-expressing dendritic cells dominate in polymyositis and dermatomyositis","volume":"40","author":"Gendek-Kubiak","year":"2013","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0560","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/cei.12319","article-title":"Enhanced formation and impaired degeneration of neutrophil extracellular traps in dermatomyositis and polymyositis: a potential contributor to interstitial lung disease complications","volume":"177","author":"Zhang","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032366","article-title":"Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones","volume":"7","author":"Saffarzadeh","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2018.01.026_bb0570","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/14397595.2016.1179861","article-title":"Abnormally increased low-density granulocytes in peripheral blood mononuclear cells are associated with interstitial lung disease","volume":"27","author":"Zhang","year":"2017","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0580","first-page":"239","article-title":"Immunolocalization of complement C1s and matrix metalloproteinase 9 (92\u202fkDa gelatinase\/type IV collagenase) in the primary ossification center of the human femur","volume":"277","author":"Sakiyama","year":"1994","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.autrev.2018.01.026_bb0585","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/ATVBAHA.117.309002","article-title":"Neutrophil extracellular traps drive endothelial-to mesenchymal transition","volume":"37","author":"Pieterse","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0590","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1046\/j.1523-1747.1999.00580.x","article-title":"Prevalence and antigen specificity of anti-histone antibodies in patients with polymyositis\/dermatomyositis","volume":"112","author":"Kubo","year":"1999","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0595","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/mus.20088","article-title":"Monocyte\/macrophage differentiation in dermatomyositis and polymyositis","volume":"30","author":"Rostasy","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.autrev.2018.01.026_bb0600","first-page":"49","article-title":"Distinct inflammatory properties of late-activated macrophages in inflammatory myopathies","volume":"27","author":"Rostasy","year":"2008","journal-title":"Acta Myol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0605","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00401-015-1384-5","article-title":"Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory eggs comes before the degenerative chicken","volume":"129","author":"Benveniste","year":"2015","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0610","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/acn3.419","article-title":"Immune and degenerative pathomechanisms in inclusion body myositis","volume":"4","author":"Keller","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0615","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/cdd.2015.171","article-title":"Cell death, clearance and immunity in the skeletal muscle","volume":"23","author":"Sciorati","year":"2016","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.autrev.2018.01.026_bb0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpath.2013.06.003","article-title":"Overexpression of MHC class I in mucle of lymphocyte-deficient mice causes a severe myopathy with induction of the unfold protein response","volume":"183","author":"Fr\u00e9ret","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9440(10)63089-1","article-title":"Endoplasmic reticulum stress and unfolded protein response in inclusion body myositis muscle","volume":"164","author":"Vattemi","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.autrev.2018.01.026_bb0630","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.bbadis.2014.09.005","article-title":"Sporadic inclusion-body myositis: a degerative muscle disease associated with aging, impaired muscle protein homeostasis and abnormal mitophagy","volume":"1852","author":"Askanas","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.autrev.2018.01.026_bb0635","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2013.00107","article-title":"When aging reaches CD4+ T-cells: phenotypic and functional changes","volume":"4","author":"Moro-Garc\u00eda","year":"2013","journal-title":"Front Immunol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721830137X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156899721830137X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T09:32:34Z","timestamp":1720344754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156899721830137X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":125,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S156899721830137X"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2018.01.026","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune checkpoint failures in inflammatory myopathies: An overview","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2018.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}